Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion type Assertion NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_head.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion description "[In addition, CRMP2 phosphorylation at the Cdk5 and GSK3 sites is increased in cortex and hippocampus of the triple transgenic mouse [presenilin-1 (PS1)(M146V)KI; Thy1.2-amyloid precursor protein (APP)(swe); Thy1.2tau(P301L)] that develops AD-like plaques and tangles, as well as the double (PS1(M146V)KI; Thy1.2-APP(swe)) transgenic mouse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_provenance.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion evidence source_evidence_literature NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_provenance.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion SIO_000772 17683481 NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_provenance.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion wasDerivedFrom befree-20140225 NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_provenance.
- NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_assertion wasGeneratedBy ECO_0000203 NP905477.RA3sbXsr_tnsXItxhF2EiFGkLckyPOySxq_pskNRqBzxA130_provenance.